Ruben V. Uribe
Ruben V. Uribe
Project coordinator at The Novo Nordisk Foundation Center for Biosustainability - DTU
Verified email at
Cited by
Cited by
Discovery and characterization of Cas9 inhibitors disseminated across seven bacterial phyla
RV Uribe, E van der Helm, MA Misiakou, SW Lee, S Kol, MOA Sommer
Cell host & microbe 25 (2), 233-241. e5, 2019
Altering microbial populations and modifying microbiota
J Clube, M Sommer, C Grøndahl, E VAN DER HELM, R Vazquez-uribe
US Patent 9,701,964, 2017
Predictable modulation of cancer treatment outcomes by the gut microbiota
Y Heshiki, R Vazquez-Uribe, J Li, Y Ni, S Quainoo, L Imamovic, J Li, ...
Microbiome 8 (1), 1-14, 2020
Antibiotics create a shift from mutualism to competition in human gut communities with a longer-lasting impact on fungi than bacteria
B Seelbinder, J Chen, S Brunke, R Vazquez-Uribe, R Santhaman, ...
Microbiome 8 (1), 1-20, 2020
Metabolic modeling predicts specific gut bacteria as key determinants for Candida albicans colonization levels
MH Mirhakkak, S Schäuble, TE Klassert, S Brunke, P Brandt, D Loos, ...
The ISME Journal, 1-14, 2020
Single-vector type i vectors
V Martinez, R Vazquez-uribe, A Takos, E VAN DER HELM, J Clube
US Patent App. 16/201,736, 2020
Inhibitors of crispr-cas associated activity
R Vazquez-Uribe, E Van Der Helm, MOA Sommer, MA Misiakou, SW Lee
WO Patent 2,019,185,751, 2019
CRISPR-Cas antimicrobials: Resistance mechanisms
R Vazquez-Uribe
Technical University of Denmark, 2018
Profiling bacterial kinase activity using a genetic circuit
E van der Helm, R Bech, CE Lehning, R Vazquez-Uribe, MOA Sommer
A high-throughput platform to select for regulators of crispr-cas associated activity
R Vazquez-Uribe, E Van Der Helm, MOA Sommer, SW Lee
Expression of the catalytic domain of a cysteine proteinase from Trichomonas vaginalis in E.coli as a soluble polypeptide
R Vázquez-Uribe, RE Cardenas-Guerra, IC Flores-Pucheta, R Arroyo
The system can't perform the operation now. Try again later.
Articles 1–11